The role of chemokines and chemokines receptors in cutaneous T cell lymphomas;Rola chemokin i ich receptorów w chłoniakach T-komórkowych pierwotnie wywodza̧cych siȩ ze skóry

Przeglad Dermatologiczny

Volumn 91, Issue 6, 2004, Pages 509-515

  Sokołowska Wojdyło, Małgorzata ^a   Roszkiewicz, Jadwiga ^a  

^a Klin Dermatol   (Poland)

Author keywords

CCL27; CCR10; CCR4; CCR7; Chemokine receptores; Chemokines; Mycosis fungoides; Sezary syndrome

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE CCL27; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR10; UNCLASSIFIED DRUG;

CLONE; CUTANEOUS T CELL LYMPHOMA; HUMAN; HUMAN CELL; KERATINOCYTE; LYMPHOCYTE; MEMORY CELL; MYCOSIS FUNGOIDES; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; SEZARY SYNDROME; T LYMPHOCYTE;

EID: 13244286587     PISSN: 00332526     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Hansen E.: Immunoregulatory events in the skin of patients with cutaneous T-cell lymphoma. Arch Dermatol 132, 554-561, 1996.
2. Willemze R., Kerl H., Sterry W. i inni: EORTC Classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymhpoma Study Group of the European Organization for Research and Treatment of Cancer Blood 1997, 90, 354-371.
3. Muche J.M., Lukowsky A., Asadullah K. i inni: Demonstration of frequent occurrence of clonal T cells in the blood of patients with primary cutaneous T-cell lymphoma. Blood 1997, 90, 1636-1642.
4. Robert C., Kupper T.S.: Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med 1999, 341, 1817-1828.
5. Sallusto F., Mackay C.R., Lanzavecchia A.: The role of chemokine receptors in primary, effector and memory immune responses. Ann Rev Immunol 2000, 18, 593-620.
6. Picker L.J., Kishimoto T.K., Smith C.W. i inni: ELAM-1 is an adhesion molecule for skin-homing T-cells. Nature 1991, 349, 769-779.
7. Fuhlbridge R.C., Kieffer J.D., Armerding D. i inni: Cutaneous lymphocyte antigen is specialized form of PSGL-1 expressed on skin-homing T-cells. Nature 1997, 389, 978-981.
8. Tietz W., Allemand Y., Borges E. i inni: CD4+ T cells migrate into inflamed skin only if they express ligands for E- and P-selectin. J Immunol 1998, 161, 963-970.
9. Erdmann I., Scheidegger E.P., Koch F.K. i inni: Fucosyl-transferase VII-deficient mice with defective E-, P-, and L-selectin ligands show impaired CD4+ and CD8+ T cell migration into the skin, but normal extravasation into visceral organs. J Immunol 2000, 168, 2139-2146.
10. van Andrian U.H., Mackay C.R.: T-cell function and migration. N Engl J Med 2000, 343, 1020-1034.
11. Picker L.J., Michie S.A., Rott L.S. i inni: A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol 1990, 136, 1053-1068.
12. Heald P.W., Yan S.L., Edelson R.L. i inni: Skin-selective lymphocyte homing mechanisms in the pathogenesis of leukemic cutaneous T-cell lymphoma. J Invest Dermatol 1993, 101, 222-226.
13. Kunkel E.J., Butcher E.C.: Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002, 16, 1-4.
14. Baggiolini M., Dewald B., Moser B.: Human chemokines: an update. Ann Rev Immunol 1997, 15, 675-705.
15. Homey B., Mueller A., Zlotnik A.: Chemokines: agents for the immunotherapy of cancer? Nat Rev Immunol 2002, 2, 175-184.
16. Gunn M.D., Tangemann K., Tam C. i inni: A chemokine expressed in lymphoid high endothelial vessels promotes the adhesion and chemotaxis of naïve T lymphocytes. Proc Natl Acad Sci USA 1998, 95, 258-263.
17. Campbell J.J., Bowman E.P., Murphy K. i inni: 6-C-kine (SLC) a lymphocyte adhesion-triggering chemokine expressed by high endothelium is an agonist for the MIP-3b receptor CCR7. J Cell Biol 1998, 141, 1053-1059.
18. Campbell J.J., Haraldsen G., Pan J. i inni: The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestingal memory T cells. Nature 1999, 400, 776-780.
19. Morales J., Homey B., Vicari A. i inni: CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 1999, 96, 14470-14475.
20. Homey B., Alenius H., Miller A. i inni: CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nature Med 2002, 8, 157-165.
21. Reiss Y., Proudfoot A.E., Power C.A. i inni: CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 2001, 194, 1541-1547.
22. Sallusto F., Lenig D., Förster R. i inni: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401, 708-712.
23. Hudak S., Hagen M., Liu Y. i inni: Immune surveillance and effector functions of CCR10+ skin homing T cells. J Immunol 2002, 169, 1189-1196.
24. Ferenczi K., Fuhlbrigge R.C., Pinkus J.L. i inni: Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 2002, 119, 1405-1410.
25. Jones D., O'Hara C., Kraus M.D. i inni: Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood 2000, 96, 685-690.
26. Kallinich T., Muche J., Quin S. i inni: Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides. J Invest Dermatol 2003, 121, 1045-1052.
27. Vestergaard C., Deleuran M., Gesser B. i inni: Expression of the T-helper 2-specific chemokine receptor CCR4 on CCR10-positive lymphocytes in atopic dermatitis skin but not in psoriasis skin. Br J Dermatol 2003, 149, 457-463.
28. Tensen C., Vermeer M., van der Stoop P. i inni: Intraepidermal interferon-γ inducible protein-10 (IP-10) and monokine induced by ãinterferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism, in cutaneous T cell lymphomas. J Invest Dermatol 1998, 111, 222-226.
29. Wojdylo M., Lenz J., Speuser P. i inni: Circulating CD4+ T cells in Sezary syndrome express CCR7 as well as may represent a malignant expansion of cutaneous central memory T cells. Arch Dermatol Res 2004, 295, 358.
30. Szczerkowska-Dobosz A.: Współczesne pogla̧dy na etiopatogenezȩ i leczenie łuszczycy. Słiżba Zdrowia 2001, 3010-3011.
31. Pinz J.C.: The role of T cells in psoriasis. JEADV 2003, 17, 257-270.
32. Foss F.M.: Interleukin-2 fusion toxin: targeted therapy for cutaneous T cell lymphoma. Ann N Y Acad Sci 2001, 941, 166-176.
33. Rook A.H., Kuzel T.M., Olsen E.A.: Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin-12, and interleukin-2. Hematol Oncol Clin North Am 2003, 17, 1435-1448.
34. Dearden C.E., Matutes E., Catovsky D.: Alemtuzumab in T-cell malignancies. Med Oncol 2002, 19, 27-32.
35. Zlotnick A., Yoshie O.: Chemokines: a new classification system and their role in immunity. Immunity 2000, 12, 121-127.